Arkolith/Insider Trading/ITRM/Form 4

Dunne Michael W.

DirectorIterum Therapeutics plc (ITRM) · full profile →Form 4 · filed Aug 12, 2025
Net Buying
Open-Market Buys
$11K
Open-Market Sells
$0
Net Open-Market Flow
$11K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 8, 2025Buy(P)15K$0.72$11K235K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-106908) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML